Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ParvOryx in Glioblastoma Multiforme
NCT01301430Phase 2Completed
- Start
- Sep 2011
- Primary completion
- May 2015
- Modality
- Oncolytic Viruses
- Countries
- 1
01
Overview
A Phase 2 trial of ParvOryx in glioblastoma multiforme (GBM). Started Sep 2011; status: completed.
02
Drugs
ParvOryx
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT01301430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01301430.